Session

Evaluation of risk in comorbidity in onco-urology

ESU Course 47

  • Location:
    Room 11 (ICM, Level 1)
  • Chair:
     N. Mottet, Saint-Étienne (FR)
  • Aims and objectives of this session

    Senior adults represent a growing population with specific problems. Individual life expectancy is a key decision driver . . . provided it is approachable.
    The key points to be covered are the following
    • Age by itself is usually irrelevant, unlike comorbidities
    • Survival predictive factor exist, combined in practical tools
    • Reliable screening tools for geriatrician referral exist
    • A multidisciplinary program with geriatricians is key

Introduction: Who we are, objectives
 N. Mottet, Saint-Étienne (FR)
Senior adults: A growing population
 S. O'Hanlon
Senior adults are undertreated
 N. Mottet, Saint-Étienne (FR)
Age is not a key factor regarding major surgery (muscle invasive bladder experience)
 N. Mottet, Saint-Étienne (FR)
Clinical cases (to set the scene): Evaluation of comorbidities in practice / individual life expectancy
 N. Mottet, Saint-Étienne (FR)
 
 S. O'Hanlon
How to evaluate individual life expectancy in practice
 S. O'Hanlon
How to evaluate individual comorbidities in practice
 S. O'Hanlon
An example of the added value of a dedicated program and its prerequisites / what to do in real life
 S. O'Hanlon
Conclusion
 N. Mottet, Saint-Étienne (FR)